Thrombocytopenia in Patients With Atrial Fibrillation on Oral Anticoagulation Undergoing Percutaneous Coronary Intervention
In conclusion, mild to moderate baseline thrombocytopenia does not seem to have a clinically significant effect on bleeding or thrombotic or thromboembolic complications after PCI in these frail patients receiving multiple antithrombotic drugs.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Tuomas Kiviniemi, Pasi Karjalainen, Andrea Rubboli, Axel Schlitt, Petri Tuomainen, Matti Niemelä, Mika Laine, Fausto Biancari, Gregory Y.H. Lip, K.E. Juhani Airaksinen Tags: Coronary Artery Disease Source Type: research
More News: Academia | Angioplasty | Atrial Fibrillation | Bleeding | Cardiology | Clopidogrel | Coronary Angioplasty | Heart | Heart Attack | Hospital Management | Ischemic Stroke | Percutaneous Coronary Intervention | Plavix | Stroke | Thrombocytopenia | Thrombosis | Vitamins